InvaGen Pharmaceuticals, Inc. and Cipla USA, Inc. are recalling 1,240 boxes of Vigabatrin for Oral Solution (500 mg per packet) because the individual medication pouches may be defective and leak powder. If the medicine leaks, patients may receive a lower dose than prescribed, which can lead to serious health complications like worsening seizures. No incidents or injuries have been reported to date.
A leaking pouch can lead to an underdose of medication, potentially causing a loss of seizure control or leading to a medical emergency. If you notice powder leaking from the packaging, the dosage may be incorrect.
You have 2 options:
Recall #: D-0220-2024
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release (1) · FDA Press Release (2) · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.